国際医薬品開発研究ジャーナル

  • ISSN: 0975-9344
  • ジャーナル h-index: 44
  • 雑誌引用スコア: 59.93
  • ジャーナルのインパクトファクター: 48.80
インデックス付き
  • Genamics JournalSeek
  • 中国国家知識基盤 (CNKI)
  • サイテファクター
  • シマゴ
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • OCLC-WorldCat
  • パブロン
  • ミアル
  • 大学補助金委員会
  • ユーロパブ
  • Google スカラー
  • シェルパ・ロメオ
  • 秘密検索エンジン研究所
  • リサーチゲート
このページをシェアする

抽象的な

Recent Findings and Development of 3D Printing Technology in Pharmaceutical
Formulation Development: An Extensive Review

Sankha Bhattacharya*, Sushil Kumar Singh, Shubham Shrestha, Yudhishthir Singh Baghel, Debalina Maity, Akhil Kumar, Ghanshyam Das Gupta, Raj Kumar Narang, Gaurav Goyal and Sourabh Kosey

Three-dimensional (3D) printing technology is an emerging and flourishing technique which has a tremendous
potential to bring a paradigm shift in the pharmaceutical sector. Basically, 3D printing is a fabrication technique in
which automatically layer-by-layer materials are being deposited to create various design of choice. The primary
objective of this manuscript is to discuss modern methods, techniques, and current trends, polymers of choice and
recent applications of 3D printing technology applying in the pharmaceutical sector. Recently, the FDA has approved
3D printed tablet called Spritam, which brings a tremendous boost in the preparation of fabricated drug delivery
system and personalized medicine. In this review, special importance was given to highlight the challenges and
future perspectives of 3D printed technology in the pharmaceutical sector.